ScienceDex / Researcher record
Arthur P Bertolino
- Cytoagents, Inc. (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $994,859 | 1 | #15,207 |
| 2025 | $2,318,698 | 2 | #5,238 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY2025 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1928106Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award records by amount
NIH award records listing Arthur P Bertolino as a PI. Multi-PI records show the full award amount for context.
- 1R44CA295189-01A1R44Contact PICTO1681 to prevent and mitigate cytokine release syndrome in multiple myeloma patients receiving CAR T-cell therapy$1.3Maward amount
- 5R44CA287634-02R44Contact PICTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients$1Maward amount
Award organization
Organizations that administered FY2025 awards listing Arthur P Bertolino as a PI.
FY2025 award administered by Cytoagents, Inc. (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCytoagents, Inc.
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #5238